1. D. Willcutts , “Specialty Pharmaceuticals: Developing a Management Plan,”Managed Care Quarterly10, no. 4 ( 2002 ): 26 –29.
2. B.L. Hesselgrave , “Helping to Manage the High Cost of Rare Diseases,”Managed Care Quarterly11, no. 1 ( 2003 ): 1 –6.
3. D. Willcutts , “Developing a Management Plan,”Managed Care Quarterly11, no. 1 ( 2003 ): 7 –10.
4. M. Edlin , “Specialty Pharmacies Provide Pipeline for Low-Volume, High-Cost Biotech Drugs,”Managed Healthcare Executive(1 June 2003 ): 36 –37.
5. A. Humphreys and C. Boersig, “Twelfth Annual Report, Top 100 Biotechnology Companies, the Ups and Downs of Biotechnology,”Med Ad News22, no. 1 ( 2003 ): 40 –45.